aod9604 clinical trial obesity The Journey of AOD-9604: From Trials to Cosmetic Triumphs AOD-9604 – 5mg – Prime

AOD-9604 has superior plasma stability (longer half-life) and is the only fragment that completed Phase 2b clinical trials in obesity

When 5-amino-1MQ increases cellular NAD+ levels, it enhances mitochondrial function, the powerhouses responsible for converting nutrients into usable cellular energy

The authors also noted that further optimisation was needed, including work relating to high clearance in mice and off-target activity against monoamine oxidase A

Serum B12, methylmalonic acid, and homocysteine directly reflect B12 status and methylation capacity

Retrieved on July 27, 2026 from MLA Bennett, Chloe

Safety and Personalized Plans While many peptides are used off-label, working with a knowledgeable physician is essential